Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1211-1220 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|April 23, 2004
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemiasA Lasa, M J Carnicer, A Aventín, et al.
Leukemia|August 5, 2005
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosminH Quentmeier, M P Martelli, W G Dirks, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
Leukemia|January 1, 1992
Treatment of acute non lymphoid leukemia (ANLL) in elderly patients. The GIMEMA experienceL Resegotti
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
Leukemia|April 9, 2005
New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genesA Kohlmann, C Schoch, M Dugas, et al.
Leukemia|April 9, 2005
Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrancesY Guo, K Karube, R Kawano, et al.
Leukemia|April 9, 2005
Identification of Ki23819, a highly potent inhibitor of kinase activity of mutant FLT3 receptor tyrosine kinaseY Komeno, M Kurokawa, Y Imai, et al.
Leukemia|April 15, 2005
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant eraT A Alonzo, R J Wells, W G Woods, et al.
Leukemia|March 18, 2005
HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3S Nagel, M Scherr, H Quentmeier, et al.
Pageof 963

Showing results (1211-1220 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|April 23, 2004
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemiasA Lasa, M J Carnicer, A Aventín, et al.
Leukemia|August 5, 2005
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosminH Quentmeier, M P Martelli, W G Dirks, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
Leukemia|January 1, 1992
Treatment of acute non lymphoid leukemia (ANLL) in elderly patients. The GIMEMA experienceL Resegotti
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
Leukemia|April 9, 2005
New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genesA Kohlmann, C Schoch, M Dugas, et al.
Leukemia|April 9, 2005
Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrancesY Guo, K Karube, R Kawano, et al.
Leukemia|April 9, 2005
Identification of Ki23819, a highly potent inhibitor of kinase activity of mutant FLT3 receptor tyrosine kinaseY Komeno, M Kurokawa, Y Imai, et al.
Leukemia|April 15, 2005
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant eraT A Alonzo, R J Wells, W G Woods, et al.
Leukemia|March 18, 2005
HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3S Nagel, M Scherr, H Quentmeier, et al.
Pageof 963